This review looks at evidence and program models for alternatives to hospitalization to treat serious infections in people who inject drugs.
This case study profiles how a federally qualified health center (FQHC) in New York provides integrated medical and behavioral health care services for individuals with opioid addiction.
This linked report details the work of integrating service for opioid use disorder treatment and infectious disease prevention and treatment. The report highlights programs that have successfully integrated treatment and provides recommendations for overcoming common barriers to service integration.
This 1-page infographic explains the STOP practice for reducing stress. Part of a collection of stress reduction materials compiled by Montifiore Health System for their patients during the COVID-19 pandemic.
This 4-page guide from the Providers Clinical Support System is designed to provide information for clinicians on using telemedicine to treat opioid use disorder (OUD) during the COVID-19 pandemic. This guide includes frequently asked questions about prescribing medications for OUD during this time,
This 4 page guide from the New York State Office of Mental Health addesses approaches to reducing stress during the COVID-19 pandemic.
This 1-page guide from the Montifiore Health System provides information on managing stress and maintaining function during the COVID-19 pandemic. The information is based on acceptance and commitment therapy (ACT) treatment models.
This 1-page guide provides a visualization exercise to help patients manage stress during the COVID-19 pandemic. The visualization exercise is based on the acceptance and commitment therapy (ACT) model and is intended to help patients manage negative thinking.
This 1-page document provides a step-by-step guide for clinicians using Apple Face Time to consult with patients during the COVID-19 pandemic.
This 3-page guide provides patients information on reducing stress during the COVID-19 pandemic by creating personal calm through grounding.